Replacement therapy
Ascendis Pharma Secures FDA Approval for YORVIPATH, a Novel Hormone Replacement Therapy for Hypoparathyroidism
Ascendis Pharma, YORVIPATH, FDA approval, hormone replacement therapy, hypoparathyroidism, TransCon PTH, palopegteriparatide
Haleon Sells Nicotine Replacement Therapy Business to Dr. Reddy’s for $630 Million
Haleon, Dr. Reddy’s, nicotine replacement therapy, business sale, $630 million
Ascendis Hormone Replacement Therapy Faces Setback with FDA Review Extension
Ascendis Pharma, hormone replacement therapy, FDA review, delay, three-month extension.